Synergistic combination effect of cidofovir and idoxuridine on vaccinia virus replication

Antiviral Chemistry and Chemotherapy

Volumn 17, Issue 2, 2006, Pages 53-58

  Remichkova, Mimi ^a   Petrov, Nikolay ^a   Galabov, Angel S ^a  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

Author keywords

Cidofovir; Combination effect; Idoxuridine; Vaccinia virus

Indexed keywords

CIDOFOVIR; IDOXURIDINE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CHICK EMBRYO; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOTOXICITY TEST; DRUG EFFECT; DRUG POTENTIATION; DRUG SENSITIVITY; EMBRYO; FIBROBLAST CULTURE; IC 50; IN VITRO STUDY; MAXIMUM TOLERATED DOSE; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS REPLICATION;

EID: 33646456920     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020601700201     Document Type: Article

References (36)

1. Barnard DL, Stowell VD, Seley KL, Hegde VR, Das SR, Rajappan VP, Schneller SW, Smee DF & Sidwell RW (2001) Inhibition of measles virus replication by 5′-nor carbocyclic adenosine analogues. Antivirial Chemistry and Chemotherapy 12:241-250.
2. Bauer DJ & Sadler DW (1960) The structure-activity relationships of the antiviral chemotherapeutic activity of isatin-thiosemicarbazone. British Journal of Pharmacology 15:101-110.
3. Borysiewicz J, Mizerski J & Pryjma J (1977) Effect of methisazone on immune response in mice. Chemotherapy 23:276-281.
4. Brownie KA & Hamre D (1951) Studies on chemotherapy of vaccinia virus. I. An experimental design for testing antiviral agents. Journal of Bacteriology 61:127-134.
5. Citarella RV, Müller R, Schlabach A & Weissbach A (1972) Studies on vaccinia virus-directed deoxyribonucleic acid polymerase. Journal of Virology 10:721-729.
6. De Clercq E (2001) Vaccinia virus inhibitors as a paradigm for chemotherapy of poxvirus infections. Clinical Microbiology Reviews 14:382-397.
7. Deria A, Jegek Z, Markvart K, Carrasco P & Weissbach A (1972) The world's last endemic case of smallpox: surveillance and containment measures. Bulletin of the World Health Organization 58:279-283.
8. Evans DH, Magee W & Hosteller KY (2004) Inhibition of orthopoxvirus DNA polymerases by cidofovir diphosphate: in vitro enzymatic studies using highly purified vaccinia virus DNA polymerase. Antiviral Research; 62:A74
9. Fenner F, Henderson DA, Arita I, Jesek Z & Landy ID (1988) Smallpox and its Eradication. Geneva: World Health Organization Press.
10. Heiner G, Szczeniowski M & Esteves K (1998) Reemergence of monkeypox in Africa: a review of the past six years. British Medical Bulletin 54:693-702.
11. Huggins JW, Martinez MJ, Hartmann CJ, Hensley LE, Jackson DL, Kefauver DF, Kulesh DA, Larsen T, Miller DM, Mucker EM, Shamblin JD, Tate MK, Whitehouse CA, Zwiers SH & Jahrling PB (2004) Successful cidofovir treatment of smallpox-like disease in variola and monkeypox primate models. Antiviral Research 62:A76.
12. Keith KA, Hitchcock MJM, Lee WA, Holy A & Kern ER (2003) Evaluation of nucleoside phosphonates and their analogs and pro-drugs for inhibition of orthopoxvirus replication. Antimicrobial Agents and Chemotherapy 47:2193-2198.
13. Kern ER, Hartline C, Harden E, Keith K, Rodriguez N, Beadle JR & Hostetller KY (2002) Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalcyl esters of cidofovir and cyclic cidofovir. Antimicrobial Agents and Chemotherapy 46:991-995.
14. Kit S, Jorgensem GN, Liav A & Zaslavsky V (1977) Purification of vaccinia virus-directed deoxyribonucleic acid polymerase. Journal of Virology 10:721-729.
15. Kuhl JI, Huerter CJ & Hashish H (2003) A case of human org contracted from a deer. Cutis 71:288-290.
16. Loddo B, Munton S & Ferrari W (1975) Effect of 5-iodo-2′ deoxyuridine on vaccinia virus, in vitro. Nature 198:510.
17. Mahy BW (2003) An overview on the use of a viral pathogen as a bioterrorism agent: why smallpox? Antiviral Research 57:15.
18. McCabe D, Weston B & Storch G (2003) Treatment of orf poxvirus lesion with cidofovir cream. Pediatric Infectious Diseases Journal 22:1027-1028.
19. McCrea JF & Lipman BB (1967) Strand-length measurments of normal and 5-iodo-2′-deoxyuridine-treated vaccinia virus deoxyribonucleic acid released by the Kleinschmidt method. Journal of Virology 1:1037-1044.
20. Müller WEG (1979) Mechanisms of action and pharmacology: chemical agents. In Antiviral Agents and Viral Diseases of Man; pp. 77-149. Edited by GJ Galasso, TC Merigan and RA Buchanan. New York: Raven Press.
21. Murray RI (2004) Conjunctival Molluscum contagiosum. Eye 18:740.
22. Neyts J & De Clercq E (1993) Efficacy of (S)-1-(3-hydroxy-2- phosphonylmethoxypropyl) cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice. Journal of Medical Virology 41:242-246.
23. Neyts J, Verbeken E & De Clercq E (2002) Effect of 5-iodo-2′ -deoxyuridine on vaccinia virus (ortopoxvirus) infections in mice. Antimicrobial Agents and Chemotherapy 46:2842-2847.
24. Nikolaeva L & Galabov AS (1999) Cytotoxicity of the synergistic antienteroviral combination of enviroxime and disoxaril. Acta Virologica 43:263-265.
25. Pancheva-Golovinska S (1975) Synergistic action of distamycin A and hyroxyurea on the replication of DNA viruses in cell cultures. Acta Virologica 19:73-77.
26. Prichard MN, Aseltine KR. & Shipman CJr (1992) MacSynergy™ II. Version 1.0. Users manual. University of Michigan, Ann Arbor.
27. Prichard MN & Shipman C (1990) A three-dimensional model to analyse drug-drug interactions. Antiviral Research 14:181-206.
28. Prusoff WH & Goz B (1973) Potential mechanism of action of antiviral agents. Federation Proceedings 32:1679-1687.
29. Roy CJ, Baker R, Weshburn K & Bray M (2003) Aerosolized cidofovir is retained in the respiratory tract and protects mice against intranasal cowpox virus challenge. Antimicrobial Agents and Chemotherapy 47:2933-2937.
30. Silverberg N (2003) Pediatric Molluscum contagiosum: optimal treatment strategies. Pediatric Drugs 5:505-512.
31. Sinjono I & Wigand R. (1981) Combined inhibition of vaccinia virus multiplication by inhibitors of DNA synthesis. Chemotherapy 27:179-183.
32. Smee DF, Baily KW & Sidwell RW (2000) Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir. Antiviral Chemistry and Chemotherapy 11:303-309.
33. Smee DF, Huffman JH, Morrison, AC, Barnard DL & Sidwell RW (2001) Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities. Antimicrobial Agents and Chemotherapy 45:743-748.
34. Smee DF & Sidwell RW (2004) Anti-cowpox virus activities of certain adenosine analogs, arabinofuranosyl nucleosides. Nucleosides Nucleotides Nucleic Acids 23:375-383.
35. Smee DF, Sidwell RW, Kefauver D, Bray M & Huggins JW (2002) Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox and vaccinia virus. Antimicrobial Agents and Chemotherapy 46:1329-1335.
36. Snoeck R, Holy A, Dewolf-Peeters C, Van Den Oord J, De Clercq E & Andrei G (2002) Antivaccinia activities of acyclic nucleoside phosphonate derivatives in epithelial cells and organotypic cultures. Antimicrobial Agents and Chemotherapy 46:3356-3361.